Adaptive Biotechnologies Corporation (ADPT) delivered a return of 81.60% over the past year. Since ADPT does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Adaptive Biotechnologies Corporation one year ago would be worth $18,160 today, representing a gain of $8,160.

Adaptive Biotechnologies Corporation (ADPT) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For ADPT, the total return equals the price-only return.

Yes, Adaptive Biotechnologies Corporation (ADPT) outperformed the S&P 500 by 60.76 percentage points over the past year. ADPT delivered a total return of 81.60%, compared to the S&P 500's 20.84%. This 60.76pp alpha means investors in ADPT earned more than a passive S&P 500 index fund.

Adaptive Biotechnologies Corporation (ADPT) experienced a maximum drawdown of -39.35% over the past year, declining from its peak on 2025-11-24 to its trough on 2026-03-27. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Adaptive Biotechnologies Corporation (ADPT)'s long-term returns with dividends reinvested. Over 10 years, the total return is -52.0% (-7.1% CAGR) — $10,000 would have grown to $4,799. Over 20 years: -52.0% total return (-3.6% CAGR) — $10,000 → $4,799. Over 30 years: -52.0% total return (-2.4% CAGR) — $10,000 → $4,799. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Adaptive Biotechnologies Corporation's best calendar year was 2025 with a total return of 162.4%. Its worst year was 2022 with a total return of -73.6%. This range shows the volatility investors should expect — the difference between the best and worst year is 235.9 percentage points.